Professor Abraham Kuten

Oncologist Prof. Abraham Kuten was appointed volunteer Chairman of the ICA in January 2019, replacing Prof. Eliezer Robinson, who stepped down after 22 years in this role. Prof. Kuten studied medicine at Hadassah Medical School at The Hebrew University in Jerusalem, and completed his residency in Medical and Radiation Oncology at Rambam Medical Center in Haifa. Prof. Kuten is Head of the Oncology Service at the Italian Hospital in Haifa. 

Prof. Kuten has published hundreds of articles in renowened medical journals as well as chapters in books on raditaion oncology in various types of cancer. 

• Prof. Kuten's appiontments include:

• Chairman, Israel Cancer Association
• Head, Oncology Service, Italian Hospital of Haifa, IL
• Head, Advisory Board, Lissod Oncology Hospital, Kiev, UA
• Head, Israeli Board Examinations Committee in Oncology (2014-2019)
• Member, Israel Ministry of Health Oncology National Council
• Member, AROME Executive Board
• Past Member, Steering Committee, EORTC-ROG (-2014)
• Director, Division of Oncology, Rambam Health Care Campus, Haifa,IL (1996-2013)
  
  
  

• His academic and clinical research activities include:

• Author and co-author – 250 publications
• Retired colonel, IDF reserves
• Active participation, EORTC Radiation Oncology Group (ROG) clinical trials
• Clinical studies on the role of XRT/XRT+CT in solid tumors.
• Development of treatment techniques for external RT and brachytherapy
• Development of modern RT planning
• TSEI in mycosis fungoides
• Development of QA/QC procedures for radiotherapy
• Development of Intra-Operative Radiotherapy (IORT)
  
  

• His academic appiontments include:

• Associate Clinical Professor, Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel, 1992-2013 
• Associate Professor of Radiation Medicine, Brown University, Providence RI, USA, 1984, 1985, 1989-90, 1993     
• Consultant and Lecturer, The Naval Hospital of Newport, RI, USA, 1984-85           
• Visiting Professor, Radiation  Oncology Center, Mallinckrot Institute of Radiology, Washington University, St. Louis MO, USA, 1987-88      
  
  

• Prof. Kuten recieved the following grants:

• QA in external beam radiotherapy and brachytherapy - International Atomic Energy Agency [IAEA], Vienna, 1997 [in collaboration with M. Cederbaum MSc and Raquelle Bar Deroma DSc.] $175,000
  
  

• 3D treatment planning for conformal RT for cancer - North Carolina-Israel Scientific Research Program [administered by the Israel Binational Scientific Foundation], 1999 [in collaboration with Drs. Halperin and Marks, Duke University, North Carolina] $55,000 [1st year]
  
  

• Development and implementation of a quality assurance program for intensity modulated radiation therapy (IMRT) and fractionated stereotactic radiotherapy (FSR) - Funding agent: International Atomic Energy Agency ($185,000)(2003)
  
  

• Phase II Israeli multicenter clinical trial of prophylactic irradiation to the contralateral breast of BRCA mutation carriers undergoing treatment for breast cancer - In collaboration with E. Evron MD ($45,000, Israel Cancer Association) (2008)